3 ms·
Look at the five-year charts for Moderna and BioNTech and it's pretty clear they've gone back to a more normal valuation.
by ceejayoz 3y ago
Look at the five-year charts for Moderna and BioNTech and it's pretty clear they've gone back to a more normal valuation.